Tempest Therapeutics (TPST) EPS (Diluted) (2020 - 2026)
Tempest Therapeutics (TPST) EPS (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 0.15 |
| 10 | Tempest Therapeutics | 4.46 Mn | 3.66 Mn | - | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.34 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -3.24 |
| Jun 30, 2025 | -2.78 |
| Mar 31, 2025 | -3.23 |
| Dec 31, 2024 | -6.60 |
| Sep 30, 2024 | -5.48 |
| Jun 30, 2024 | -5.74 |
| Mar 31, 2024 | -4.88 |
| Dec 31, 2023 | -1.43 |
| Sep 30, 2023 | -6.41 |
| Jun 30, 2023 | -7.21 |
| Mar 31, 2023 | -7.49 |
| Dec 31, 2022 | -10.54 |
| Sep 30, 2022 | -8.63 |
| Jun 30, 2022 | -10.37 |
| Mar 31, 2022 | -16.05 |
| Dec 31, 2021 | -13.00 |
| Sep 30, 2021 | -16.44 |
| Jun 30, 2021 | -99.15 |